Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy

Abstract

Abstract Prostacyclin therapy is a mainstay of the management of pulmonary arterial hypertension (PAH). Inhaled prostacyclins present safe and effective options for the management of PAH that limit systemic side effects. We describe the first reported case of life‐threatening bronchospasm and acute respiratory failure associated with inhaled prostacyclin administration.

Keywords

• epoprostenol
• pulmonary hypertension
• treprostinil